InvestorNewsBreaks

Friday May 16, 2025 - 9:20 am

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Advances NV-387 Antiviral Program, Prepares for Multiple Phase II Trials

NanoViricides, Inc. (NYSE American: NNVC) filed its Q1 2025 report and announced progress on NV-387, its broad-spectrum antiviral drug candidate. The company has received clearance from the DRC's National Ethics Committee to submit a Phase II trial application for MPox and is also initiating programs targeting measles and avian flu. NV-387 previously completed Phase I with no adverse events and has shown superior activity in…

Friday May 16, 2025 - 9:10 am

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Prices $2 Million Public Offering of Common Stock and Warrants

Silo Pharma (NASDAQ: SILO) has priced a public offering of approximately 3.33 million shares of common stock (or pre-funded warrants) along with Series A-1 and Series A-2 warrants, all priced at $0.60 per unit. The Series A-1 and A-2 warrants are immediately exercisable at $0.60 per share, with expirations set at five years and eighteen months, respectively. Gross proceeds are expected to total roughly $2…

Friday May 16, 2025 - 9:00 am

InvestorNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) CEO Highlights Vertical Integration and $184M Asset Base on GotStocks Podcast

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (CSE: SUNN) President and CEO Dr. Richard Lu appeared on the GotStocks Podcast to discuss the company’s vertically integrated model and its $184 million portfolio of revenue-generating clean energy assets. Lu detailed how SolarBank develops, builds, owns, and operates distributed and community solar projects across Canada and the U.S., including partnerships with Honeywell and Qcells. He…

Friday May 16, 2025 - 9:00 am

InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q1 Results, Highlights Progress on Ketamine NDA and HOPE Clinic Rollup

NRx Pharmaceuticals (NASDAQ: NRXP) reported a Q1 2025 net loss of $5.5 million, down from $6.5 million in the same period last year, with operating losses narrowing to $3.8 million. The company advanced regulatory and commercial milestones for its two lead programs: NRX-100, a preservative-free IV ketamine formulation for suicidal depression now supported by an NDA fee waiver and new patent filing; and NRX-101, an…

Thursday May 15, 2025 - 3:36 pm

InvestorNewsBreaks – Adageis’ Fintech Platform Drives Smarter, More Profitable Healthcare

Adageis, a forward-thinking healthcare technology company, is empowering clinics and medical groups to succeed in the shift from fee-for-service to value-based care through its AI-powered platform. The company’s ProActive Care solution deciphers complex insurance contracts, integrates with leading EHR systems, and offers real-time analytics to help providers track revenue trends as well as their performance and profitability. Proprietary components of the platform, including the Value-Based…

Thursday May 15, 2025 - 2:32 pm

InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances

Nutriband (NASDAQ: NTRB), a company focused on the development of a portfolio of transdermal pharmaceutical products, is expanding its market presence and manufacturing capabilities through two new strategic partnerships. The company is collaborating with Charlotte FC to build brand visibility, particularly for its AI Tape and AVERSA(TM)—Nutriband’s proprietary technology that it believes has the potential to be the world’s first and only abuse deterrent patch…

Thursday May 15, 2025 - 12:54 pm

InvestorNewsBreaks – Zacks Research Issues Business Update as Soligenix Inc. (NASDAQ: SNGX) Continues Enrollment in Confirmatory Phase 3 HyBryte Trial

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted this week in a Zacks Small-Cap Research report that presented a favorable analysis, noting that the company’s Phase 3 cutaneous T-cell lymphoma (“CTCL”) study is continuing and that the trial has a high probability of success. According to the report, Soligenix is conducting a Phase 3 FLASH2 trial of HyBryte(TM) in patients with…

Thursday May 15, 2025 - 12:30 pm

InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Secures $7.8M to Launch Clinic Rollup Strategy

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its wholly owned subsidiary, HOPE Therapeutics(TM), has signed a term sheet with Universal Capital, LLC for $7.8 million in acquisition funding to support the rollout of its national interventional psychiatry clinic network. Combined with previously announced investments, HOPE now has $10.3 million in capital to execute initial acquisitions of Dura Medical, Kadima, and NeuroSpa. These clinics offer neuroplastic treatments…

Thursday May 15, 2025 - 10:10 am

InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally

Intelligent Bio Solutions (NASDAQ: INBS) reported continued commercial growth, surpassing 450 active accounts with 35 added in fiscal Q3, driven by demand for its rapid, non-invasive fingerprint drug testing system. The company expanded into new sectors including luxury marine, retail, and waste management, while entering remote regions across Europe and Australia. INBS now operates in 24 countries and partners with 18 distributors across 19 nations.…

Thursday May 15, 2025 - 10:00 am

InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Unveils Breakthrough Silver(II) Antimicrobial Drug Candidate Telomir-Ag2

Telomir Pharmaceuticals (NASDAQ: TELO) announced the identification of Telomir-Ag2, a stabilized Silver(II) complex demonstrating potent, broad-spectrum antimicrobial activity, including against drug-resistant MARSA. Developed using the company’s proprietary Telomir-1 platform, Telomir-Ag2 is the first Silver(II) compound to achieve biological compatibility, outperforming its Silver(I) predecessor in preclinical studies. Designed for use in high-risk infections such as burns and surgical wounds, the drug candidate targets the growing $1.36…

Thursday May 15, 2025 - 10:00 am

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Reaffirms $50M 2026 Revenue Target Ahead of CSI Acquisition Close

Datavault AI (NASDAQ: DVLT) filed Q1 2025 results and reaffirmed its 2026 revenue target of $40 million to $50 million, projecting $12 million to $15 million in revenue in the second half of 2025. The company expects to close its acquisition of CompuSystems Inc. during the week of May 19. Recent strategic milestones include joining IBM’s Partner Plus, licensing its ADIO(R) ultrasonic advertising tech to…

Thursday May 15, 2025 - 9:58 am

InvestorNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Advances Redtail Virotherapy Platform and Reduces Q1 Losses

Calidi Biotherapeutics (NYSE American: CLDI) reported a Q1 2025 net loss of $5.0 million, narrowing from $7.2 million in the prior year, with R&D and G&A expenses also declining. The company highlighted FDA clearance of its IND for CLD-201, an allogeneic stem cell-based immunotherapy for solid tumors, and presented promising Redtail platform data at AACR showcasing IL15 superagonist delivery via engineered oncolytic virus. Calidi also…

Thursday May 15, 2025 - 9:50 am

InvestorNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Applauds Imminent Eagle Football IPO, Sees Boost for Multi-Club Investment Visibility

Brera Holdings (NASDAQ: BREA) welcomed reports that Eagle Football Holdings, a $2 billion multi-club ownership group, is preparing to file for an IPO. Eagle’s portfolio includes stakes in Crystal Palace, Lyon, Botafogo, and Molenbeek. Brera Executive Chairman Dan McClory expressed support for the move, citing its potential to raise investor awareness of the MCO model and sports as an asset class. Brera, which completed its…

Thursday May 15, 2025 - 9:40 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Taps Thermo Fisher for Phase 3 and Commercial Production of CYB003

Cybin (NYSE American: CYBN) (NEO: CYBN) has partnered with Thermo Fisher Scientific to support Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin treatment for major depressive disorder (MDD). The agreement expands on Cybin’s existing U.S.-based manufacturing operations, with Thermo Fisher handling drug substance in South Carolina and capsule production in Ohio. CYB003 received FDA Breakthrough Therapy Designation in March…

Thursday May 15, 2025 - 9:30 am

InvestorNewsBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Reports Record Q1 Revenue and Expands Plug & Play Footprint

SKYX Platforms (NASDAQ: SKYX) reported record Q1 2025 revenue of $20.1 million, up 6% year-over-year, driven by growth in its smart and standard plug & play product sales. The company’s gross profit rose to $5.7 million while net loss per share narrowed to ($0.09). SKYX raised $4 million in new equity as part of a $15 million financing round led by The Shaner Group and…

Thursday May 15, 2025 - 9:20 am

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Engages Veloxity Labs for IND-Enabling Study of PTSD Drug SPC-15

Silo Pharma (NASDAQ: SILO) has partnered with Veloxity Labs to conduct GLP-compliant bioanalysis for its ongoing toxicology and toxicokinetics study of SPC-15, an intranasal treatment aimed at preventing PTSD. The data will support an FDA investigational new drug submission expected in 2025. If approved, Silo plans to advance SPC-15 into a Phase 1 human clinical trial. To view the full press release, visit https://ibn.fm/Bo8ag About…

Thursday May 15, 2025 - 9:15 am

InvestorNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Reports 246% Revenue Growth and Expanding Tour Adoption in Q1

Newton Golf Company (NASDAQ: NWTG) reported a 246% year-over-year revenue increase to $1.2 million in Q1 2025, driven by surging demand for its Newton Motion and Fast Motion shafts. Gross profit rose to $852,000 with margin expansion to 70%, while net loss narrowed to $0.5 million. More than 30 professionals have adopted Newton shafts, including 8 new players across major tours in Q1. The company…

Thursday May 15, 2025 - 9:10 am

InvestorNewsBreaks – G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) Delivers Free Cash Flow and $24.4M Q1 Profit, Advances Oko West

G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) reported Q1 2025 gold production of 35,578 ounces at an all-in sustaining cost of $960/oz, generating $24.4 million in net income and $36.0 million in free cash flow. With $149 million in cash and no lost time or recordable incidents, the company remains on track to meet 2025 guidance. GMIN advanced early works at Oko West and…

Thursday May 15, 2025 - 9:00 am

InvestorNewsBreaks – Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) Launches New Investor Awareness Campaigns Across North America and Europe

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) has initiated a series of investor awareness and marketing agreements aimed at expanding its visibility. The Company engaged InvestorBrandNetwork for a yearlong communications campaign starting May 8, 2025, at $23,200 per quarter, and Goldinvest Consulting for six months beginning May 5 to support outreach in Germany at EUR 4,050 per month. Ucore also signed a 12-month media agreement…

Thursday May 15, 2025 - 9:00 am

InvestorNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Report Q1 2025 Results and Host Investor Webinar Today

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) will release its financial results for the quarter ended March 31, 2025, after market close today, May 15, and will host a webinar at 4:30 p.m. ET to provide a business update and discuss the quarterly performance. To view the full press release, visit https://ibn.fm/PSk5q About SolarBank Corporation SolarBank Corporation is…

Thursday May 15, 2025 - 9:00 am

InvestorNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Reports Q1 Revenue of $14.5M, Expands Airtime Business Despite Healthcare Headwinds

NextPlat (NASDAQ: NXPL, NXPLW) reported Q1 2025 revenue of $14.5 million, down from $17.5 million in the prior year, driven by changes in 340B pharmacy agreements and prescription volume. Gross margin declined to 23.8%, while operating expenses fell 26% to $4.9 million due to reduced legal and non-recurring costs. Net loss narrowed to $1.3 million, or ($0.05) per share. The company ended the quarter with…

Wednesday May 14, 2025 - 3:20 pm

InvestorNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Set to Report Q1 Earnings in Wake of HOPE’s Strategic Kadima Agreement

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is scheduled to report its first quarter 2025 financial results after the market closes on Thursday, May 15. A conference call and webcast will follow at 4:30 p.m. ET, accessible via the company’s investor relations site or by dialing +1-800-717-1738 (U.S.) or +1-646-307-1865 (international). The earnings update comes shortly after news that NRx’s wholly owned subsidiary, HOPE Therapeutics, signed a…

Wednesday May 14, 2025 - 3:13 pm

InvestorNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Positioned to Accelerate Storm Copper Project in Nunavut

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), through its joint venture with American West Metals, has secured a strategic partnership with Ocean Partners Holdings to significantly advance the Storm Copper Project in Nunavut, Canada. The deal includes up to 80% project development financing and a binding offtake agreement granting Ocean Partners exclusive rights to copper and silver products from near-surface mineralization. Backed by a US$3.5 million…

Wednesday May 14, 2025 - 2:49 pm

InvestorNewsBreaks – Whoopi Goldberg to Take the Stage at CMB 2025

Cannabis Means Business (“CMB”) today announced that Whoopi Goldberg will participate in a fireside chat and launch her new hemp-derived beverage, Whoop-Tea, at CMB 2025, taking place on June 4–5 at the Javits Center in New York City. The Emmy, Grammy, Oscar, and Tony Award-winning entertainer and entrepreneur will join CNBC’s Tim Seymour on Wednesday, June 4, for an exclusive conversation in the Special Events…

Wednesday May 14, 2025 - 12:15 pm

InvestorNewsBreaks – From Farm to Future: Sustainability in Focus at Sustain SoCal’s May Event

Sustain Southern California (“Sustain SoCal”) has announced its upcoming event, Agriculture, Food Systems and Waste Stream Innovations, slated to take place in Irvine, California, on Thursday, May 15, 2025. The synergistic agenda will drive comprehensive discussions along the entire spectrum of the supply chain, from agtech, farm-to-table, packaging innovations, and waste management policy. “We are pleased to offer a new initiative… which shall provide a…

Wednesday May 14, 2025 - 11:49 am

InvestorNewsBreaks – SurgePays, Inc. (Nasdaq: SURG) Secures $7M Convertible Note to Fuel LinkUp Mobile Launch and Wholesale Expansion

SurgePays (Nasdaq: SURG) has entered into a $7 million senior secured convertible note agreement with a current institutional shareholder, providing $6 million in cash and involving a repurchase of 333,333 shares. The two-year note is convertible into common stock at $4.00 per share, a premium to current market price, and includes a prepayment option at a 2% premium. Proceeds will support the national launch of…

Wednesday May 14, 2025 - 10:00 am

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances PTSD Treatment with FDA-Requested Safety Study for SPC-15

Silo Pharma (NASDAQ: SILO) has partnered with Frontage Laboratories to conduct a 7-day safety and toxicology study of its lead asset, SPC-15, following a request from the FDA. The intranasal treatment targets PTSD and stress-related disorders, and the study is expected to strengthen Silo’s upcoming IND application. Silo remains on track for an FDA submission this year and is concurrently running a GLP-compliant toxicology study.…

Wednesday May 14, 2025 - 9:50 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Grows Q1 Revenue 29% and Narrows Losses Ahead of Investor Showcase

Knightscope (NASDAQ: KSCP) reported Q1 2025 revenue of $2.9 million, up 29% year-over-year, while net loss narrowed to $6.9 million, a 19% improvement. The company improved gross margin loss to (23%) from (64%) and cut G&A expenses by 24%. Knightscope ended the quarter with $12.7 million in cash and a $2.5 million backlog. Strategic initiatives included securing a 33,000-square-foot headquarters in Sunnyvale, California, and raising…

Wednesday May 14, 2025 - 9:45 am

InvestorNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Highlights Near-Term Production Strategy on MiningNewsWire Podcast

ESGold (CSE: ESAU) (OTCQB: ESAUF) President Brad Kitchen appeared on the latest episode of The MiningNewsWire Podcast to discuss the company’s fully permitted Montauban project and near-term path to gold and silver production. Kitchen emphasized ESGold’s unique model of funding exploration through early-stage tailings production, citing an estimated $100 million in recoverable material from the historic mine. He also highlighted the project’s community impact, operational…

Wednesday May 14, 2025 - 9:40 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Joseph Hand as General Counsel and EVP of Operations

Tonix Pharmaceuticals (NASDAQ: TNXP) has appointed Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations. Hand brings decades of leadership experience across legal, HR, and corporate services, including a pivotal role in Celgene’s $74 billion acquisition by Bristol Myers Squibb and the $13.4 billion divestiture of Otezla® to Amgen. His addition comes as Tonix prepares for a potential launch of TNX-102 SL…

Wednesday May 14, 2025 - 9:35 am

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Advances NV-387 Antiviral as Measles and MPox Resurge Globally

NanoViricides, Inc. (NYSE American: NNVC) provided a strategic update on its antiviral pipeline, highlighting NV-387 as a potential breakthrough treatment for Measles and MPox amid rising global case counts and vaccine failures. The company has begun preparations for animal efficacy studies for Measles and will make NV-387 available under FDA’s Individual Patient Expanded Access. In the DRC, its Phase II Clinical Trial Application for MPox…

Wednesday May 14, 2025 - 9:30 am

InvestorNewsBreaks – FAVO Capital Inc. (FAVO) to Present Growth Strategy at D. Boral Capital Inaugural Global Conference

FAVO Capital (OTC: FAVO), a provider of revenue-based funding solutions for SMBs, announced its participation in the D. Boral Capital Inaugural Global Conference on May 14, 2025, at The Plaza Hotel in New York City. President Shaun Quin will represent the company in meetings with institutional investors, highlighting FAVO’s growth strategy and IPO readiness. CEO Vincent Napolitano emphasized the event as a key platform to expand…

Wednesday May 14, 2025 - 9:30 am

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update

HeartBeam (NASDAQ: BEAT) reported Q1 2025 results highlighted by successful completion of the VALID-ECG pivotal study, supporting its 510(k) submission for 12-lead ECG synthesis software and confirming productive ongoing FDA discussions. The company launched an Early Access Program, signed a strategic partnership with AccurKardia to integrate its FDA-cleared AccurECG(TM) software, added two new U.S. patents to bring its IP total to 20, appointed CEO Robert…

Wednesday May 14, 2025 - 9:20 am

InvestorNewsBreaks – SOBRsafe Inc. (NASDAQ: SOBR) Appoints Kris Pederson to Board, Adds Scientific Advisor to Advance Tech and Governance

SOBRsafe (NASDAQ: SOBR) has appointed Kris Pederson, a veteran corporate director with leadership roles at EY, IBM (NYSE: IBM), and PwC, to its Board of Directors effective May 1, 2025, where she will also chair the Nominating and Corporate Governance Committee. The Company also named Dr. Benjamin Sanchez as a Scientific Advisor in February to support federal funding and clinical research partnerships. The additions bring…

Wednesday May 14, 2025 - 9:20 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at Alliance Global Partners Healthcare Showcase on May 21

Cybin (NYSE American: CYBN) (NEO: CYBN) announced that CEO Doug Drysdale will participate in a fireside chat at the virtual Alliance Global Partners Healthcare Company Showcase on May 21, 2025. The session will be webcast live at 1:40 p.m. ET and later available via the company’s investor relations site. To view the full press release, visit https://ibn.fm/6a3sj About Cybin Inc. Cybin is a clinical-stage biopharmaceutical…

Wednesday May 14, 2025 - 9:10 am

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Advances Phase 3 Alzheimer’s Trial and Expands Conference Presence in Q1

Annovis Bio (NYSE: ANVS) initiated its pivotal Phase 3 clinical trial in early Alzheimer’s disease during Q1 2025, with enrollment now underway for up to 760 participants to assess buntanetap’s symptomatic and disease-modifying effects over 18 months. The company also secured a new U.S. patent for buntanetap and participated in several key scientific and investor conferences, including Oppenheimer’s 35th Annual Healthcare Life Sciences Conference and…

Wednesday May 14, 2025 - 9:10 am

InvestorNewsBreaks – Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) Expands North American REE Refining Plans as RapidSX(TM) Nears Commissioning

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) is nearing the commissioning of its RapidSX(TM) Commercial Demonstration Plant in Kingston, Ontario, a key milestone in its plan to commercialize its advanced rare earth element (REE) separation technology. The company is also preparing to construct its first Strategic Metals Complex (SMC) in Louisiana, expected to process 2,000 tons of total rare earth oxides by the end of…

Wednesday May 14, 2025 - 9:05 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Prices $5 Million Public Offering with Institutional Investor

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on brain and central nervous system cancers, has priced a “reasonable best efforts” public offering with a single healthcare-focused institutional investor, raising approximately $5 million in gross proceeds. The offering includes 3,952,570 shares of common stock at $1.265 per share and accompanying Series F warrants to purchase an equal number of shares at $1.14 per share, exercisable…

Wednesday May 14, 2025 - 9:00 am

InvestorNewsBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Secures $4 Million Strategic Investment as Part of $15 Million Funding Round

SKYX Platforms (NASDAQ: SKYX), a smart home platform technology company with over 97 issued and pending patents, announced it has raised approximately $4 million from strategic investors through preferred stock priced at $2.00 per share. The investment is part of a broader $15 million financing round led by The Shaner Group, with additional participation from SKYX insiders including President Steve Schmidt and Co-CEOs Lenny Sokolow…

Tuesday May 13, 2025 - 1:30 pm

InvestorNewsBreaks – MoneyShow’s Virtual Expo to Deliver Strategic Insights on Maximizing Potential in Volatile Times

MoneyShow, a leading producer of live and online financial conferences for investors, traders, and financial advisors, today announced the upcoming “Navigating Volatility, Finding Opportunity: A Virtual Expo,” set to take place May 21-22, 2025. “Investors face several key issues in this market environment. They include far-reaching U.S. tariffs, geopolitical tensions, inflation concerns, evolving trade dynamics, the potential for interest rate cuts, and the surge in…

InvestorNewsBreaks

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions